Tension mounts as Evonik presses ahead

The decision to launch the €3.5bn-€5bn IPO of Evonik last Friday morning generated mixed reviews from ECM bankers with some worried that Europe’s flagship transaction will be a hostage to market and political sentiment. This week, reports that Rothschild has been added as a second adviser stoked suggestions of tension among the parties involved.